News und Analysen
Raven Industries Awarded Prime Contract for Stratospheric Balloon Systems & Services
Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that Defense Innovation Unit (DIU) has awarded a contract to Aerostar Technical Solutions, Inc. (Raven Aerostar) to provide robust
Humana Announces Value-Based Agreement with Allina Health in Minnesota
Humana Inc. (NYSE: HUM), a leading health and well-being company, and Allina Health are expanding their existing agreement to focus on value-based care for Humana’s Medicare Advantage members in
Eaton Demonstrates Long-term Resiliency With Microgrid at Fort Hood, Texas
Power management company Eaton, in partnership with the U.S. Army Engineer Research and Development Center (ERDC), Construction Engineering Research Laboratory (CERL), and the Department of Public
Inseego Corp. Statement on Infrastructure Investment and Jobs Act
Inseego Corp. (Nasdaq: INSG), a leader of 5G and intelligent IoT device-to-cloud solutions for enterprises and consumers, congratulates the U.S. Congress and President Joseph R. Biden for a
ICON Releases Environmental, Social and Governance Report
ICON plc (NASDAQ:ICLR) announced today the release of its 2020 Environmental, Social and Governance (ESG) Report. With the completion of ICON’s acquisition of PRA Health Sciences, the report
State Street Collateral+ Delivers New Analytics and Optimization Capabilities in Partnership with Cassini Systems
State Street Corporation (NYSE:STT) announced today it has added market leading pre-and post-trade optimization and margin analytics capabilities to its Collateral+ service. In partnership with
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the phase 3 pivotal LUNAR trial evaluating the efficacy of Tumor Treating Fields (TTFields) together with immune
Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced that the
Philip Morris International’s ESG Performance Recognized by S&P Dow Jones Indices; Company Included in Dow Jones Sustainability Index North America for Second Consecutive Year
Philip Morris International Inc. (PMI) (NYSE: PM) has been included for the second consecutive year in the Dow Jones Sustainability Index (DJSI) North America. The index recognizes the top 20
NICE Adds Powerful Innovations to Optimize Workforce Management and Improve Experiences for Digital Consumers
The massive increase in digital channel adoption has added significant complexity to workforce management forecasting and scheduling. To help organizations address this development, NICE (Nasdaq:
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX) today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX) today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15
Mannatech Declares Special 2021 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
E-Auto-Boom lässt Aktien explodieren! (Tesla, BYD, Rivian, Nio, VW)
E-Auto-Boom lässt Aktien explodieren! (Tesla, BYD, Rivian, Nio, VW)
GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Dassault Systèmes Enters the S&P Dow Jones Sustainability World Index
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced it has been included in the Dow Jones Sustainability Indices for the first time, ranking fifth in the software
Dassault Systèmes Enters the S&P Dow Jones Sustainability World Index
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced it has been included in the Dow Jones Sustainability Indices for the first time, ranking fifth in the software
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and Zenas
SAP SE - Fundamental Analysis
.png?locale=de "FinanceClub_UoM")
SAP SE - Fundamental Analysis
SAP SE - Fundamental Analysis
Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that investigators presented results from the neratinib arm of the Phase II Individualized Screening Trial of
PLUG POWER INC.- Technical Analysis
Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it participated in a